Drug:
Reaction: GAIT DISTURBANCE
20250101 - 20251231
No. 501 - 600
No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
501 | 25045009 |
DE |
25 | 2 |
Suicidal ideation, Seizure, Nightmare, Hypotonia, Dizziness, Movement disorder, Tachycardia, Muscular weakness, Myalgia, Asthenia, Fatigue, Malaise, Insomnia, Anxiety, Chills, Gait disturbance, Feeling abnormal, Hyperhidrosis, Cognitive disorder, |
||||
SERTRALINE, SERTRALINE, SERTRALINE, |
||||
502 | 25045152 |
CA |
43 | 2 |
Alopecia, Amnesia, Anxiety, Asthenia, Asthma, Blood cholesterol increased, Breast cancer stage II, Condition aggravated, Confusional state, Contusion, Decreased appetite, Deep vein thrombosis postoperative, Delirium, Depression, Discomfort, Dislocation of vertebra, Drug hypersensitivity, Dry mouth, Duodenal ulcer perforation, Dyspepsia, Dyspnoea, Facet joint syndrome, Fatigue, Fibromyalgia, Folliculitis, Gait disturbance, Glossodynia, Grip strength decreased, Hand deformity, Headache, Helicobacter infection, Hip arthroplasty, Hypertension, Hypoaesthesia, Impaired healing, Infection, Inflammation, Infusion related reaction, Injury, Intentional product use issue, Irritable bowel syndrome, Knee arthroplasty, Lip dry, Liver injury, Lower limb fracture, Lower respiratory tract infection, Lung disorder, Lupus vulgaris, Malaise, Migraine, Muscle injury, Muscle spasms, Muscular weakness, Musculoskeletal pain, Nasopharyngitis, Night sweats, Obesity, Osteoarthritis, Pain, Paraesthesia, Pemphigus, Pericarditis, Peripheral venous disease, Product use issue, Psoriatic arthropathy, Pyrexia, Rheumatic fever, Rheumatoid arthritis, Road traffic accident, Sciatica, Sinusitis, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Swelling, Systemic lupus erythematosus, Type 2 diabetes mellitus, Urticaria, Weight decreased, Weight increased, Wound infection, Maternal exposure during pregnancy, Off label use, Contraindicated product administered, Medication error, Drug ineffective, Abdominal discomfort, Blister, Breast cancer stage III, Blepharospasm, Abdominal pain upper, Anti-cyclic citrullinated peptide antibody positive, Bursitis, Arthralgia, Arthropathy, C-reactive protein increased, Diarrhoea, Dizziness, Epilepsy, Gastrooesophageal reflux disease, General physical health deterioration, Hepatic enzyme increased, Peripheral swelling, Abdominal pain, Autoimmune disorder, Vomiting, Chest pain, Drug intolerance, Gait inability, Gastrointestinal disorder, Hypercholesterolaemia, Hypersensitivity, Ill-defined disorder, Joint range of motion decreased, Joint swelling, Liver disorder, Mobility decreased, Musculoskeletal stiffness, Oedema, Oedema peripheral, Rash, Pruritus, Respiratory tract infection, Rheumatoid factor positive, Swollen joint count increased, Synovitis, Product use in unapproved indication, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, APREMILAST, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ATOMOXETINE HYDROCHLORIDE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, BUPRENORPHINE, CALCIUM CARBONATE, ANTACID, CALCIUM GLUCONATE, CELECOXIB, CELECOXIB, CELECOXIB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, SECUKINUMAB, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC, DICLOFENAC SODIUM, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, AZATHIOPRINE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, BUPIVACAINE HYDROCHLORIDE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, ABATACEPT, PREGABALIN, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, PREDNISONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, RITUXIMAB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, CANDESARTAN CILEXETIL, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOFACITINIB, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, LORAZEPAM, |
||||
503 | 25045211 |
ZA |
76 | |
Back disorder, Immunodeficiency, Gait disturbance, |
||||
ROSUVASTATIN, LEFLUNOMIDE, |
||||
504 | 25045379 |
BR |
2 | |
Death, Cerebrovascular accident, Vasculitis, Gangrene, Limb discomfort, Pain in extremity, Wheelchair user, Sitting disability, Loss of personal independence in daily activities, Bedridden, Hypokinesia, Gait disturbance, Visual impairment, Tongue discomfort, Fall, |
||||
AGALSIDASE BETA, |
||||
505 | 25045587 |
US |
60 | |
Sepsis, Asthma, Arrhythmia, Parainfluenzae virus infection, Dyspnoea, Wheezing, Chest discomfort, Productive cough, Sinus pain, Pyrexia, Weight increased, Fatigue, Ear pain, Nausea, Dyspepsia, Chest pain, Oedema, Malaise, Dysphonia, Myalgia, Rhinorrhoea, Heart rate increased, Paranasal sinus discomfort, Oropharyngeal pain, Chills, Hyperhidrosis, Rhinitis allergic, Procedural pneumothorax, Hiatus hernia, Lung disorder, Bloody discharge, Oxygen saturation decreased, Nasal congestion, Joint swelling, Arthralgia, Dizziness, Tremor, Headache, Amnesia, Hypoaesthesia, Paraesthesia, Gait disturbance, Contusion, Obstructive sleep apnoea syndrome, Seasonal allergy, Breath sounds abnormal, Bronchitis, Lymphadenopathy, |
||||
BUDESONIDE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, ALBUTEROL SULFATE, ALBUTEROL, |
||||
506 | 25045602 |
US |
1 | |
Dizziness, Balance disorder, Gait disturbance, |
||||
PIMAVANSERIN TARTRATE, PIMAVANSERIN TARTRATE, |
||||
507 | 25045612 |
US |
2 | |
Asthenia, Hypoaesthesia, Gait disturbance, Peroneal nerve palsy, Contusion, Pain in extremity, Joint swelling, Drug ineffective, |
||||
OFATUMUMAB, |
||||
508 | 25045735 |
US |
71 | 2 |
Arthropathy, Gait disturbance, Inability to afford medication, Suspected counterfeit product, |
||||
APIXABAN, APIXABAN, |
||||
509 | 25045766 |
US |
2 | |
Rib fracture, Gait disturbance, |
||||
PIMAVANSERIN TARTRATE, CALCIUM, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
510 | 25045880 |
US |
17 | 1 |
Swelling, Systemic lupus erythematosus, Photophobia, Somnolence, Vomiting, Pain, Palpitations, Migraine, Nausea, Weight increased, Gait disturbance, Off label use, |
||||
VOCLOSPORIN, VOCLOSPORIN, |
||||
511 | 25045950 |
US |
67 | 2 |
Coronary arterial stent insertion, Abdominal discomfort, Malaise, Condition aggravated, Gait disturbance, Pain, Insomnia, Pain, Procedural complication, |
||||
ADALIMUMAB, IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, IBUPROFEN TABLET COATED, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
512 | 25046635 |
CN |
58 | 2 |
Anaphylactic shock, Head discomfort, Gait disturbance, Face oedema, Erythema, Blood pressure immeasurable, Oxygen saturation decreased, Depressed mood, Heart rate increased, Nausea, |
||||
IOPROMIDE, |
||||
513 | 25046984 |
US |
74 | 2 |
Arterial occlusive disease, Osteoporosis, Pain, Gait disturbance, Panic attack, Malaise, |
||||
PALBOCICLIB, |
||||
514 | 25047033 |
IT |
4 | 2 |
Multiple-drug resistance, Seizure, Status epilepticus, Generalised tonic-clonic seizure, Atonic seizures, Gait disturbance, Abnormal behaviour, |
||||
LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, LACOSAMIDE, VIGABATRIN, VALPROIC ACID, ETHOSUXIMIDE, CLONAZEPAM, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, CANNABIDIOL, |
||||
515 | 25047089 |
US |
||
Plasma cell myeloma, Hypogammaglobulinaemia, Chemotherapy, Bronchitis, Gait disturbance, Back pain, Testicular failure, |
||||
TECLISTAMAB, TECLISTAMAB, TECLISTAMAB, TECLISTAMAB, TECLISTAMAB, TECLISTAMAB, TECLISTAMAB, TECLISTAMAB, TECLISTAMAB, |
||||
516 | 25047213 |
US |
||
Gait disturbance, Hot flush, Incorrect dose administered, |
||||
RELUGOLIX, |
||||
517 | 25047311 |
BR |
35 | 2 |
Endometriosis, Adenomyosis, Foot operation, Fall, Haematoma, Gait disturbance, Osteoarthritis, Contusion, Abdominal distension, |
||||
GOLIMUMAB, |
||||
518 | 25047958 |
US |
34 | 1 |
Urinary retention, Oxygen saturation decreased, Gait disturbance, Trismus, Extrapyramidal disorder, Lethargy, Drooling, Motor dysfunction, Musculoskeletal stiffness, Hiccups, |
||||
PALIPERIDONE PALMITATE, PALIPERIDONE PALMITATE, PALIPERIDONE PALMITATE, PALIPERIDONE PALMITATE, PALIPERIDONE PALMITATE, DEUTETRABENAZINE, |
||||
519 | 25039097 |
US |
33 | 2 |
Inappropriate schedule of product administration, Product dose omission issue, Gait disturbance, Dysarthria, Asthenia, Arthralgia, Pain in extremity, |
||||
NATALIZUMAB, NATALIZUMAB, |
||||
520 | 25039180 |
CA |
82 | 2 |
Renal failure, Wrist deformity, Finger deformity, Foot deformity, Arthralgia, Body height decreased, Fall, Overweight, Hypertension, Purpura, Diabetes mellitus, Hepatic enzyme increased, Musculoskeletal stiffness, Gait disturbance, Psoriatic arthropathy, Osteoporosis, Nephropathy, Arthropathy, Synovitis, Bone density decreased, Movement disorder, Fibrosis, Hepatic steatosis, Sciatica, Skin disorder, Joint range of motion decreased, Dyslipidaemia, Osteoarthritis, Psoriasis, Limb injury, Chest pain, Arthritis, Musculoskeletal pain, Back pain, Carbuncle, Asthenia, Dysstasia, Liver disorder, Hypothalamo-pituitary disorder, Cholelithiasis, Monoclonal immunoglobulin present, Renal cyst, Joint stiffness, |
||||
DICLOFENAC, DICLOFENAC SODIUM, TEMAZEPAM, METHOTREXATE, METHOTREXATE SODIUM, HYDROXYCHLOROQUINE, ATORVASTATIN CALCIUM, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, CALCIUM CARBONATE, ANTACID, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, LANSOPRAZOLE, RANITIDINE HYDROCHLORIDE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CALCIUM, CELECOXIB, CELECOXIB, FUROSEMIDE, GABAPENTIN, ASIAN GINSENG, IRON, LORATADINE, LORATADINE ORAL, MAGNESIUM, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, ACETAMINOPHEN AND CODEINE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ATENOLOL, FLUTICASONE FUROATE, PANTOPRAZOLE, FESOTERODINE FUMARATE, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, CITALOPRAM, CITALOPRAM HYDROBROMIDE, ERGOCALCIFEROL, SODIUM BICARBONATE, SODIUM BICARBONATE INJECTION,, ATENOLOL, DOCUSATE SODIUM, DOCUSATE SODIUM - SENNOSIDES, |
||||
521 | 25039425 |
CO |
50 | |
Gait disturbance, Hypoaesthesia oral, Medication error, Neoplasm malignant, Chronic obstructive pulmonary disease, Product use issue, Intentional product misuse, |
||||
BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
522 | 25039579 |
US |
||
Asthenia, Gait disturbance, Weight decreased, Loss of personal independence in daily activities, Abdominal discomfort, Recalled product administered, Product quality issue, Recalled product, Product solubility abnormal, |
||||
POTASSIUM CHLORIDE, |
||||
523 | 25039659 |
CA |
56 | 1 |
Anxiety, Asthma, Blood pressure systolic increased, C-reactive protein increased, Candida infection, Cataract, Cough, Drug ineffective, Dyspnoea, Gait disturbance, Headache, Heart rate increased, Hypophagia, Illness, Infection, Nasal congestion, Nasopharyngitis, Respiratory rate increased, Rheumatoid arthritis, Rhinorrhoea, Speech disorder, Stress, Vision blurred, Weight decreased, Weight increased, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE, RANITIDINE, ALBUTEROL SULFATE, ALBUTEROL, MONTELUKAST SODIUM, ALBUTEROL SULFATE, |
||||
524 | 25039881 |
CA |
97 | 2 |
Anti-cyclic citrullinated peptide antibody positive, Amnesia, Arthralgia, Arthropathy, Adjustment disorder with depressed mood, Back disorder, Blister, Blood cholesterol increased, Breast cancer stage II, Condition aggravated, Dislocation of vertebra, Fibromyalgia, Delirium, Gait disturbance, Gastrointestinal disorder, Gait inability, Folliculitis, Glossodynia, General symptom, Grip strength decreased, Hypoaesthesia, Irritable bowel syndrome, Infusion related reaction, General physical health deterioration, Lower respiratory tract infection, Liver injury, Discomfort, Hand deformity, Memory impairment, Ill-defined disorder, Mobility decreased, Injury, Migraine, Joint range of motion decreased, Rheumatoid arthritis, Hypercholesterolaemia, Pain, Pain in extremity, Muscle injury, Musculoskeletal stiffness, Pericarditis, Psoriasis, Pemphigus, Psoriatic arthropathy, Joint swelling, Pulmonary fibrosis, Pustular psoriasis, Nasopharyngitis, Myositis, Rheumatic fever, Sleep disorder, Sinusitis, Synovitis, Subcutaneous drug absorption impaired, Rheumatoid factor positive, Swollen joint count increased, Type 2 diabetes mellitus, Wheezing, Wound, Wound infection, X-ray abnormal, Abdominal discomfort, Abdominal pain upper, Alopecia, Chest pain, Confusional state, Contusion, Decreased appetite, Depression, Diarrhoea, Drug hypersensitivity, Duodenal ulcer perforation, Dyspepsia, Dyspnoea, Fatigue, Fluid retention, Headache, Helicobacter infection, Hepatic enzyme increased, Hypersensitivity, Hypertension, Nausea, Malaise, Impaired healing, Infection, Oedema, Peripheral swelling, Pneumonia, Pruritus, Pyrexia, Rash, Rash vesicular, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Swelling, Systemic lupus erythematosus, Urticaria, Vomiting, Weight decreased, Weight increased, |
||||
NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN AND CODEINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ALENDRONATE SODIUM, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, LEFLUNOMIDE, LEFLUNOMIDE, CAFFEINE, CAFFEINE, CAFFEINE, CALCIUM CARBONATE, ANTACID, CALCIUM CARBONATE, ANTACID, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CERTOLIZUMAB PEGOL, SECUKINUMAB, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC, DICLOFENAC SODIUM, ETANERCEPT, ETANERCEPT, VEDOLIZUMAB, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ADALIMUMAB, ADALIMUMAB, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, INFLIXIMAB, INFLIXIMAB, IODINE, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, SARILUMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, APREMILAST, OXYCODONE HYDROCHLORIDE, OXYCODONE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, GOLIMUMAB, GOLIMUMAB, USTEKINUMAB, SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, VITAMIN C, PREDNISONE, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, LORAZEPAM, CALCIUM, ERGOCALCIFEROL, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LANSOPRAZOLE, LISINOPRIL, LORAZEPAM, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, QUETIAPINE FUMARATE, QUETIAPINE, RAMIPRIL, SULFASALAZINE, FISH OIL, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ERGOCALCIFEROL, |
||||
525 | 25040191 |
US |
||
Gait disturbance, Incorrect dose administered, |
||||
BUROSUMAB, CETIRIZINE HYDROCHLORIDE, |
||||
526 | 25040204 |
CA |
||
Arthralgia, Fall, Gait disturbance, Musculoskeletal chest pain, Head injury, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, |
||||
527 | 25040595 |
US |
52 | 2 |
Multiple sclerosis relapse, Gait disturbance, Muscle spasticity, Peroneal nerve palsy, Mobility decreased, |
||||
OFATUMUMAB, |
||||
528 | 25040684 |
BR |
49 | 2 |
Erysipelas, Product use in unapproved indication, Joint swelling, Pain, Arthralgia, Swelling, Peripheral swelling, Mobility decreased, Muscular weakness, Product dose omission issue, Arthritis, Infection, Injection site mass, Skin wound, Arthropathy, Urinary tract infection, Pain in extremity, Hypokinesia, Wound, Malaise, Inflammation, Blister, Neck pain, Gait disturbance, |
||||
DICLOFENAC, DICLOFENAC SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, |
||||
529 | 25041056 |
US |
1 | |
Somnolence, Syncope, Physical disability, Gait disturbance, |
||||
STIRIPENTOL, CLOBAZAM, LEVETIRACETAM, FENFLURAMINE, CLONAZEPAM, |
||||
530 | 25041223 |
US |
41 | 1 |
Asthenopia, Feeling of despair, Feeling cold, Gait disturbance, Pain, Influenza like illness, Fatigue, Headache, Injection site pain, Injection site mass, Injection site discolouration, |
||||
NALTREXONE, NALTREXONE, |
||||
531 | 25041359 |
ES |
57 | 1 |
Epilepsy, Intestinal obstruction, Faecaloma, Freezing phenomenon, On and off phenomenon, Gait inability, Dyskinesia, Gait disturbance, Musculoskeletal stiffness, Back pain, Nervousness, Tremor, Hypoaesthesia, Malaise, Unevaluable event, Bezoar, Embedded device, Drug ineffective, Incorrect route of product administration, Therapy cessation, |
||||
FENTANYL, OPICAPONE, |
||||
532 | 25041554 |
US |
70 | 2 |
Gait disturbance, Fall, Spinal column injury, Spinal pain, Soft tissue swelling, Body height decreased, Diarrhoea, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
533 | 25041559 |
US |
70 | 2 |
Gait disturbance, Vision blurred, Somnolence, Stress fracture, Headache, |
||||
TERIPARATIDE, |
||||
534 | 25041568 |
CA |
59 | 2 |
Hypertension, Movement disorder, Infection, Product use in unapproved indication, Arthralgia, Dyspnoea, Cardiac failure, Injection site nodule, Inflammation, Hypotension, Pulmonary oedema, Sitting disability, Fatigue, Pain in extremity, Peripheral swelling, Pain, Joint swelling, Gait disturbance, Pelvic pain, Pleurisy, Injection site swelling, Diarrhoea, Therapeutic response decreased, Injection site pain, Alopecia, Anaemia, Feeling cold, |
||||
LEFLUNOMIDE, METHOTREXATE, METHOTREXATE SODIUM, DEXLANSOPRAZOLE, AMLODIPINE, SARILUMAB, SARILUMAB, ERGOCALCIFEROL, PREDNISONE, CONJUGATED ESTROGENS, ESTROGENS, CONJUGATED, LEVOTHYROXINE SODIUM, |
||||
535 | 25041614 |
CA |
||
Seizure, Seizure, Seizure, Seizure, Stress, Wrong technique in product usage process, Intentional product use issue, Dyskinesia, Somnolence, Fatigue, Coordination abnormal, Gait disturbance, Balance disorder, |
||||
LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, PRIMIDONE, LEVETIRACETAM, ERGOCALCIFEROL, IRON, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, IBUPROFEN TABLET COATED, |
||||
536 | 25041671 |
US |
||
Quality of life decreased, Ageusia, Gait disturbance, Muscle spasms, Myalgia, |
||||
LACTULOSE, TORSEMIDE, CARVEDILOL, |
||||
537 | 25041769 |
US |
||
Asthenia, Lymphoedema, Large intestinal haemorrhage, Oedema peripheral, Myalgia, Balance disorder, Gait disturbance, Fatigue, Product dose omission issue, |
||||
ELACESTRANT, APIXABAN, EXEMESTANE, FUROSEMIDE, GABAPENTIN, LIDOCAINE PATCH 5%, LORAZEPAM, NAPROXEN, NAPROXEN SODIUM, SENNOSIDES, ERGOCALCIFEROL, VITAMIN E, CREAM, ABEMACICLIB, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, |
||||
538 | 25041849 |
JP |
77 | 1 |
Adrenal insufficiency, Gait disturbance, |
||||
LENVATINIB, PEMBROLIZUMAB, NIFEDIPINE, ATENOLOL, AZILSARTAN KAMEDOXOMIL, NOREPINEPHRINE (BITARTRATE), NOREPINEPHRINE BITARTRATE, HYDROCORTISONE SODIUM SUCCINATE, |
||||
539 | 25042055 |
JP |
1 | |
Muscular weakness, Gait disturbance, Malaise, Decreased appetite, |
||||
OXALIPLATIN, FLUOROURACIL, PANITUMUMAB, LEVOLEUCOVORIN INJECTION, LEVOLEUCOVORIN CALCIUM, LEVOLEUCOVORIN, |
||||
540 | 25042497 |
US |
84 | 1 |
Limb injury, Gait disturbance, Weight bearing difficulty, Dyspnoea exertional, Sneezing, Headache, Epistaxis, Constipation, Pollakiuria, Decreased appetite, Weight increased, Fatigue, Asthenia, Visual impairment, Quality of life decreased, |
||||
DAROLUTAMIDE, PANTOPRAZOLE, GABAPENTIN, SACUBITRIL AND VALSARTAN, ATORVASTATIN CALCIUM, TIZANIDINE, |
||||
541 | 25042505 |
US |
58 | |
Laboratory test abnormal, Muscle spasms, Gait disturbance, Abdominal discomfort, Weight decreased, Drug ineffective, |
||||
ASFOTASE ALFA, ASFOTASE ALFA, |
||||
542 | 25042547 |
|||
Nervousness, Gait disturbance, Therapy interrupted, |
||||
FINGOLIMOD HCL, |
||||
543 | 25042875 |
US |
88 | 1 |
Gait disturbance, Asthenia, Off label use, |
||||
LENALIDOMIDE, |
||||
544 | 25042931 |
US |
69 | 2 |
Weight decreased, Muscular weakness, Musculoskeletal stiffness, Balance disorder, Gait disturbance, Coordination abnormal, |
||||
DULAGLUTIDE, |
||||
545 | 25042947 |
US |
18 | 2 |
Tricuspid valve incompetence, Cardiac steatosis, Gait disturbance, Weight decreased, |
||||
FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, |
||||
546 | 25042954 |
RS |
51 | 1 |
Musculoskeletal toxicity, Skin toxicity, Muscle spasms, Myalgia, Muscle rupture, Arthralgia, Gait disturbance, Pain in extremity, Rash, Pruritus, Alopecia, Dry skin, Fatigue, |
||||
NILOTINIB, |
||||
547 | 25043219 |
US |
||
Gait disturbance, Pain, |
||||
ZANUBRUTINIB, |
||||
548 | 25043290 |
US |
62 | 2 |
Neuropathy peripheral, Gait disturbance, Fatigue, |
||||
FRUQUINTINIB, FRUQUINTINIB, LOSARTAN POTASSIUM, LOSARTAN, ERGOCALCIFEROL, |
||||
549 | 25034123 |
CA |
||
Abdominal discomfort, Adjustment disorder with depressed mood, Alopecia, Amnesia, Anti-cyclic citrullinated peptide antibody, Anti-cyclic citrullinated peptide antibody positive, Anxiety, Arthralgia, Arthritis, Arthropathy, Autoimmune disorder, Blister, Blood cholesterol increased, Bone erosion, Breast cancer stage I, Bronchitis, C-reactive protein increased, Chest pain, Condition aggravated, Confusional state, Contusion, Crohn^s disease, Decreased appetite, Deep vein thrombosis postoperative, Delirium, Depression, Diarrhoea, Discomfort, Dislocation of vertebra, Dizziness, Drug-induced liver injury, Duodenal ulcer perforation, Dyspepsia, Dyspnoea, Ear infection, Exostosis, Fatigue, Fibromyalgia, Folliculitis, Foot deformity, Gait disturbance, Gait inability, General physical health deterioration, Glossodynia, Grip strength decreased, Hand deformity, Headache, Helicobacter infection, Hepatic cirrhosis, Hepatic enzyme increased, Hip arthroplasty, Hypercholesterolaemia, Hypersensitivity, Hypertension, Hypoaesthesia, Impaired healing, Infection, Infusion related reaction, Injury, Irritable bowel syndrome, Joint dislocation, Joint range of motion decreased, Joint stiffness, Joint swelling, Knee arthroplasty, Laryngitis, Liver function test increased, Liver injury, Lower limb fracture, Lupus vulgaris, Lupus-like syndrome, Memory impairment, Mobility decreased, Muscle injury, Muscular weakness, Musculoskeletal stiffness, Nasopharyngitis, Nausea, Oedema, Oedema peripheral, Osteoarthritis, Osteoporosis, Pain, Pain in extremity, Pemphigus, Pericarditis, Peripheral swelling, Pneumonia, Pruritus, Psoriasis, Psoriatic arthropathy, Pulmonary fibrosis, Pyrexia, Rash, Red blood cell sedimentation rate increased, Retinitis, Rheumatic fever, Rheumatoid arthritis, Rheumatoid factor positive, Road traffic accident, Sciatica, Seronegative arthritis, Sinusitis, Swollen joint count increased, Synovitis, Systemic lupus erythematosus, Tachycardia, Type 2 diabetes mellitus, Upper respiratory tract infection, Urticaria, Visual impairment, Vomiting, Weight decreased, Weight increased, Wheezing, Wound, Wound infection, Disability, Loss of personal independence in daily activities, Walking aid user, Prescribed overdose, Prescribed underdose, |
||||
CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ALENDRONATE SODIUM, APREMILAST, AZATHIOPRINE, CALCIUM, CALCIUM CARBONATE, ANTACID, CELECOXIB, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CLONIDINE HYDROCHLORIDE, CLONIDINE, HYDROCORTISONE, CORTISONE ACETATE, DESOXIMETASONE, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, ETANERCEPT, VEDOLIZUMAB, FOLIC ACID, GOLIMUMAB, ADALIMUMAB, HYDROCORTISONE SODIUM SUCCINATE, INFLIXIMAB, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, MESALAMINE, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, QUETIAPINE FUMARATE, QUETIAPINE, |
||||
550 | 25034136 |
NL |
74 | 2 |
Respiratory tract congestion, Freezing phenomenon, Tremor, Balance disorder, Muscle rigidity, Myalgia, Infusion site haemorrhage, Therapeutic product effect incomplete, On and off phenomenon, Hyperkinesia, Dyskinesia, Drug ineffective, Taste disorder, Physical disability, Nausea, Hypogeusia, Musculoskeletal stiffness, Feeling abnormal, Fluid retention, Drug ineffective, Catheter site haemorrhage, Sleep disorder, Wrong technique in device usage process, Infusion site induration, Weight decreased, Infusion site pain, Decreased appetite, Back pain, Infusion site irritation, Device difficult to use, Loss of personal independence in daily activities, Movement disorder, Muscle spasms, Infusion site erythema, Gait disturbance, Depressed mood, Loss of personal independence in daily activities, Device connection issue, Loss of personal independence in daily activities, Discomfort, Movement disorder, Aversion, Dyspnoea, Device difficult to use, Pain in extremity, Stress, Infusion site erythema, Muscle rigidity, Dyskinesia, Catheter site extravasation, Infusion site bruising, Inappropriate schedule of product administration, Infusion site induration, Dystonia, Infusion site extravasation, |
||||
FENTANYL, |
||||
551 | 25034742 |
US |
||
Multiple sclerosis relapse, Gait disturbance, |
||||
OFATUMUMAB, |
||||
552 | 25035049 |
CA |
||
Abdominal discomfort, Adjustment disorder with depressed mood, Anti-cyclic citrullinated peptide antibody positive, Arthropathy, Back disorder, Breast cancer stage II, Condition aggravated, Chest pain, Contusion, Decreased appetite, Delirium, Discomfort, Dislocation of vertebra, Duodenal ulcer perforation, Fibromyalgia, Gait inability, General physical health deterioration, Glossodynia, Grip strength decreased, Hand deformity, Hepatic enzyme increased, Ill-defined disorder, Impaired healing, Injury, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Liver injury, Malaise, Memory impairment, Mobility decreased, Musculoskeletal stiffness, Myositis, Oedema, Pain in extremity, Pericarditis, Peripheral swelling, Psoriasis, Psoriatic arthropathy, Pulmonary fibrosis, Pustular psoriasis, Rash vesicular, Rheumatic fever, Rheumatoid arthritis, Rheumatoid factor positive, Sleep disorder, Sleep disorder due to general medical condition, insomnia type, Subcutaneous drug absorption impaired, Swelling, Swollen joint count increased, Synovitis, Systemic lupus erythematosus, Type 2 diabetes mellitus, Weight decreased, Weight increased, Wound, X-ray abnormal, Muscle injury, Pemphigus, Fluid retention, Alopecia, Amnesia, Arthralgia, Blood cholesterol increased, Confusional state, Depression, Drug hypersensitivity, Dyspnoea, Gastrointestinal disorder, General symptom, Abdominal pain upper, Hypercholesterolaemia, Hypoaesthesia, Migraine, Nausea, Pain, Stomatitis, Wheezing, Blister, Diarrhoea, Dyspepsia, Folliculitis, Gait disturbance, Headache, Helicobacter infection, Hypertension, Lower respiratory tract infection, Nasopharyngitis, Pruritus, Rash, Vomiting, Wound infection, Hypersensitivity, Pneumonia, Fatigue, Infusion related reaction, Infection, Pyrexia, Sinusitis, Urticaria, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, LEFLUNOMIDE, LEFLUNOMIDE, CALCIUM CARBONATE, ANTACID, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CERTOLIZUMAB PEGOL, SECUKINUMAB, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, ETANERCEPT, ETANERCEPT, VEDOLIZUMAB, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ADALIMUMAB, ADALIMUMAB, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, INFLIXIMAB, INFLIXIMAB, IODINE, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, SARILUMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, NAPROXEN, NAPROXEN SODIUM, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, APREMILAST, OXYCODONE HYDROCHLORIDE, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, USTEKINUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, VITAMIN C, PREDNISONE, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, LORAZEPAM, CALCIUM, ERGOCALCIFEROL, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LANSOPRAZOLE, LISINOPRIL, LORAZEPAM, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, QUETIAPINE FUMARATE, QUETIAPINE, RAMIPRIL, SULFASALAZINE, FISH OIL, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ERGOCALCIFEROL, |
||||
553 | 25035060 |
US |
64 | 2 |
Urinary tract infection, Gait disturbance, |
||||
TOCILIZUMAB, |
||||
554 | 25035081 |
US |
2 | |
Thrombosis, Gait disturbance, |
||||
DIROXIMEL FUMARATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
555 | 25035088 |
JP |
||
Inappropriate antidiuretic hormone secretion, Gait disturbance, Dysphagia, Treatment noncompliance, |
||||
VALACYCLOVIR HYDROCHLORIDE, |
||||
556 | 25035233 |
CA |
97 | 2 |
Helicobacter infection, Grip strength decreased, General symptom, Discomfort, Glossodynia, Headache, General physical health deterioration, Gastrointestinal disorder, Fatigue, Fibromyalgia, Dyspnoea, Drug hypersensitivity, Duodenal ulcer perforation, Dislocation of vertebra, Dyspepsia, Gait disturbance, Hand deformity, Folliculitis, Gait inability, Fluid retention, |
||||
DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, OXYCODONE HYDROCHLORIDE, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, SECUKINUMAB, SECUKINUMAB, LORAZEPAM, |
||||
557 | 25035385 |
US |
82 | 2 |
Sciatica, Gait disturbance, Dysstasia, Off label use, |
||||
LENALIDOMIDE, |
||||
558 | 25035533 |
NL |
25 | 2 |
Angioedema, Anaphylactic reaction, Diabetes mellitus inadequate control, Urticaria, Gait disturbance, Pain in extremity, Gingival swelling, Drug ineffective, |
||||
OMALIZUMAB, OMALIZUMAB, CYCLOSPORINE, PREDNISONE, |
||||
559 | 25035557 |
US |
87 | 1 |
Gait disturbance, Dizziness, Product lot number issue, Off label use, |
||||
FAMOTIDINE, |
||||
560 | 25035861 |
ES |
76 | 2 |
Restlessness, Gait disturbance, Depressed level of consciousness, |
||||
QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, ALPRAZOLAM, DONEPEZIL HYDROCHLORIDE, MEMANTINE, MEMANTINE HYDROCHLORIDE, HALOPERIDOL, HALOPERIDOL LACTATE, |
||||
561 | 25035882 |
CA |
2 | |
C-reactive protein increased, Decreased appetite, Delirium, Hepatic enzyme increased, Hypoaesthesia, Joint stiffness, Knee arthroplasty, Laryngitis, Memory impairment, Pain, Psoriasis, Psoriatic arthropathy, Rheumatic fever, Vomiting, Abdominal discomfort, Anti-cyclic citrullinated peptide antibody positive, Chest pain, Condition aggravated, Drug-induced liver injury, Helicobacter infection, Infection, Irritable bowel syndrome, Joint swelling, Muscular weakness, Peripheral swelling, Prescribed underdose, Pruritus, Rash, Rheumatoid factor positive, Seronegative arthritis, Swollen joint count increased, Arthropathy, Autoimmune disorder, Bone erosion, Confusional state, Crohn^s disease, Depression, Disability, Dizziness, Gait disturbance, Grip strength decreased, Headache, Hepatic cirrhosis, Hip arthroplasty, Hypertension, Muscle injury, Oedema, Oedema peripheral, Osteoporosis, Rheumatoid arthritis, Sinusitis, Type 2 diabetes mellitus, Walking aid user, Weight increased, Wound infection, Arthralgia, Glossodynia, Infusion related reaction, Pemphigus, Pericarditis, Systemic lupus erythematosus, Weight decreased, Wound, Adjustment disorder with depressed mood, Contusion, Discomfort, Dyspnoea, Fatigue, Hypersensitivity, Injury, Nasopharyngitis, Prescribed overdose, Synovitis, Amnesia, Anti-cyclic citrullinated peptide antibody, Anxiety, Arthritis, Breast cancer stage I, Deep vein thrombosis postoperative, Dislocation of vertebra, Ear infection, Gait inability, Hypercholesterolaemia, Liver function test increased, Lupus vulgaris, Musculoskeletal stiffness, Osteoarthritis, Pulmonary fibrosis, Red blood cell sedimentation rate increased, Visual impairment, Alopecia, Blister, Blood cholesterol increased, Bronchitis, Diarrhoea, Dyspepsia, Fibromyalgia, Foot deformity, General physical health deterioration, Impaired healing, Joint dislocation, Joint range of motion decreased, Liver injury, Lower limb fracture, Mobility decreased, Nausea, Pain in extremity, Retinitis, Sciatica, Upper respiratory tract infection, Wheezing, Duodenal ulcer perforation, Exostosis, Folliculitis, Hand deformity, Loss of personal independence in daily activities, Lupus-like syndrome, Pneumonia, Pyrexia, Road traffic accident, Tachycardia, Urticaria, |
||||
METHOTREXATE, METHOTREXATE SODIUM, QUETIAPINE FUMARATE, QUETIAPINE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, APREMILAST, AZATHIOPRINE, CALCIUM, CALCIUM CARBONATE, ANTACID, CELECOXIB, CERTOLIZUMAB PEGOL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CERTOLIZUMAB PEGOL, CLONIDINE HYDROCHLORIDE, CLONIDINE, HYDROCORTISONE, CORTISONE ACETATE, DESOXIMETASONE, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, ETANERCEPT, VEDOLIZUMAB, FOLIC ACID, GOLIMUMAB, ADALIMUMAB, HYDROCORTISONE SODIUM SUCCINATE, INFLIXIMAB, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, MESALAMINE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, ETANERCEPT, |
||||
562 | 25036383 |
GB |
45 | 2 |
Lower respiratory tract infection, Influenza like illness, Cough, COVID-19, Gait disturbance, |
||||
OFATUMUMAB, OFATUMUMAB, |
||||
563 | 25037131 |
DE |
29 | 2 |
Paraplegia, Cerebrospinal fluid leakage, Nervous system disorder, Pain, Monoplegia, Dysstasia, Gait disturbance, Pain in extremity, Hypoaesthesia, Hyperreflexia, Sensory loss, Muscular weakness, Sciatica, Mobility decreased, Loss of control of legs, Hypoaesthesia, Muscle twitching, Urine output decreased, Cauda equina syndrome, Atonic urinary bladder, Urinary retention, Failed back surgery syndrome, Frequent bowel movements, Abnormal faeces, Anal sphincter atony, Procedural pain, |
||||
THROMBIN HUMAN AND FIBRINOGEN, THROMBIN HUMAN AND FIBRINOGEN, THROMBIN HUMAN AND FIBRINOGEN, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, |
||||
564 | 25037234 |
US |
53 | 2 |
Systemic lupus erythematosus, Therapeutic product effect decreased, Antinuclear antibody positive, Brain fog, Pain, Illness, Gait disturbance, Insomnia, |
||||
ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, METHOTREXATE SODIUM, HYDROXYCHLOROQUINE SULFATE, |
||||
565 | 25037423 |
ZA |
49 | 2 |
Multiple sclerosis relapse, Peripheral swelling, Head discomfort, Chills, Ear discomfort, Myalgia, Dyspnoea, Chest pain, Lymphadenopathy, Fatigue, Gait disturbance, Burning sensation, Pain, Pain in extremity, Malaise, Muscular weakness, |
||||
FINGOLIMOD HYDROCHLORIDE, ENALAPRIL, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
566 | 25037477 |
DE |
||
Product use issue, Hemiparesis, Paraplegia, Cerebrospinal fluid leakage, Nervous system disorder, Pain, Monoplegia, Dysstasia, Gait disturbance, Pain in extremity, Hypoaesthesia, Hyperreflexia, Sensory loss, Muscular weakness, Sciatica, Mobility decreased, Loss of control of legs, Hypoaesthesia, Muscle twitching, Urine output decreased, Cauda equina syndrome, Atonic urinary bladder, Urinary retention, Failed back surgery syndrome, Frequent bowel movements, Abnormal faeces, Anal sphincter atony, Procedural pain, |
||||
THROMBIN HUMAN AND FIBRINOGEN, THROMBIN HUMAN AND FIBRINOGEN, THROMBIN HUMAN AND FIBRINOGEN, |
||||
567 | 25037483 |
US |
2 | |
Parkinson^s disease, Bradykinesia, Gait disturbance, Parkinsonism, Dyskinesia, Tremor, |
||||
VALBENAZINE, ARIPIPRAZOLE, |
||||
568 | 25037586 |
FR |
||
Speech disorder, Gait disturbance, Asthenia, Oral discomfort, |
||||
VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR, CARBAMAZEPINE, LEVOTHYROXINE, |
||||
569 | 25037643 |
IT |
52 | 1 |
Arthralgia, Vertigo, Syncope, Pruritus, Hypertensive crisis, Gait disturbance, |
||||
DASATINIB, |
||||
570 | 25037690 |
CA |
43 | 2 |
Abdominal discomfort, Psoriatic arthropathy, Asthenia, Adjustment disorder with depressed mood, Weight increased, Dry mouth, Lip dry, C-reactive protein abnormal, Grip strength decreased, White blood cell count increased, Dizziness, Road traffic accident, Obesity, Condition aggravated, Discomfort, Osteoarthritis, Rheumatoid arthritis, Duodenal ulcer perforation, Off label use, Memory impairment, Rash, Amnesia, Wound, Gait disturbance, Inflammation, Alopecia, Adverse drug reaction, Feeling hot, Delirium, Anti-cyclic citrullinated peptide antibody positive, Rectal haemorrhage, Swelling, Pancreatitis, Decreased appetite, Intentional product misuse, Joint range of motion decreased, Blood cholesterol increased, Fatigue, Depression, Weight decreased, Sciatica, Systemic lupus erythematosus, Blister, Arthralgia, Porphyria acute, Liver disorder, Confusional state, Arthropathy, Pericarditis, Fibromyalgia, Paraesthesia, Muscle spasms, Chest pain, Therapy non-responder, Synovitis, Colitis ulcerative, Laboratory test abnormal, Wound infection, Mobility decreased, Adverse event, Rheumatoid factor positive, Irritable bowel syndrome, Dislocation of vertebra, Wheezing, Abdominal pain upper, Peripheral venous disease, Abdominal pain, Frequent bowel movements, Bursitis, Musculoskeletal pain, Night sweats, Muscular weakness, Breast cancer stage III, Drug hypersensitivity, Pain in extremity, Vomiting, Oedema peripheral, Diarrhoea, Underdose, |
||||
DICLOFENAC, DICLOFENAC SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, ALENDRONATE SODIUM, ALENDRONATE SODIUM, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, DICLOFENAC SODIUM, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, |
||||
571 | 25037999 |
CA |
76 | 1 |
Cogwheel rigidity, Eyelid function disorder, Fall, Gait disturbance, Off label use, Orthostatic hypotension, Sedation, Tremor, |
||||
CANDESARTAN CILEXETIL, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CLONAZEPAM, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, LORAZEPAM, LOXAPINE, OLANZAPINE, OLANZAPINE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, RISPERIDONE, RIVASTIGMINE, |
||||
572 | 25038353 |
US |
2 | |
Illness, Chronic respiratory failure, Hypoparathyroidism, Gait disturbance, Pallor, Abdominal discomfort, Peripheral swelling, Fall, Haemoglobin decreased, Nausea, Fatigue, Vomiting, Diarrhoea, |
||||
IMATINIB MESYLATE, IMATINIB MESYLATE, IMATINIB MESYLATE, IMATINIB MESYLATE, BOSUTINIB, BOSUTINIB, BOSUTINIB, |
||||
573 | 25038511 |
US |
2 | |
Cystitis, Road traffic accident, Fall, Ankle fracture, Shock, Fibromyalgia, Bladder disorder, Hallucination, Loss of control of legs, Gait disturbance, Intentional dose omission, Arthropathy, Panic reaction, Visual acuity reduced, Pain, Apathy, Insomnia, Constipation, Mental impairment, Fatigue, Asthenia, Nausea, Pain, Paraesthesia, Depression, |
||||
INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, |
||||
574 | 25038731 |
US |
57 | 2 |
Vertigo, Gait disturbance, Fall, Pain in extremity, Insomnia, |
||||
BELIMUMAB, METHOTREXATE, METHOTREXATE SODIUM, HYDROXYCHLOROQUINE, |
||||
575 | 25040649 |
70 | 2 | |
Sepsis, Colitis, Headache, Gait disturbance, COVID-19, |
||||
TOFACITINIB, |
||||
576 | 25050776 |
35 | ||
Gait disturbance, Weight increased, Drug intolerance, |
||||
LEVOTHYROXINE, |
||||
577 | 25029094 |
US |
2 | |
Gait disturbance, Back pain, Blood calcium decreased, Pollakiuria, Myalgia, Rash, Dyspnoea exertional, Paraesthesia, Heart rate increased, Blood pressure increased, |
||||
ROMOSOZUMAB-AQQG, CALCIUM, ERGOCALCIFEROL, ERGOCALCIFEROL, ERGOCALCIFEROL, ERGOCALCIFEROL, PHYTONADIONE, PHYTONADIONE, PHYTONADIONE, PHYTONADIONE, |
||||
578 | 25029259 |
US |
65 | 2 |
Fall, Gait disturbance, |
||||
BARICITINIB, |
||||
579 | 25029280 |
US |
58 | 2 |
Multiple sclerosis relapse, Gait disturbance, Fatigue, Hypoaesthesia, Pain in extremity, |
||||
GLATIRAMER ACETATE, |
||||
580 | 25029415 |
CA |
44 | 2 |
Grip strength, Ear infection, Drug tolerance decreased, Helicobacter infection, Respiratory disorder, Sleep disorder due to a general medical condition, Arthropathy, Asthenia, Gastrointestinal disorder, General physical health deterioration, Blood cholesterol increased, Grip strength decreased, Hand deformity, Gait disturbance, Foot deformity, Hypercholesterolaemia, Hypertension, Hypoaesthesia, Folliculitis, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, PREDNISONE, PREDNISONE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LORAZEPAM, CALCIUM, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CAFFEINE, CAFFEINE CITRATE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, FLUOROMETHOLONE, AZATHIOPRINE, ABATACEPT, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, RITUXIMAB, RITUXIMAB, ALBUTEROL SULFATE, VITAMIN C, |
||||
581 | 25029669 |
US |
51 | 1 |
Hypoxia, Oxygen saturation decreased, Hyperhidrosis, Rash, Pruritus, Gait disturbance, |
||||
RIVAROXABAN, AMLODIPINE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
582 | 25029676 |
US |
||
Respiratory disorder, Gait disturbance, |
||||
DAPAGLIFLOZIN, |
||||
583 | 25029986 |
CA |
79 | 2 |
Acute kidney injury, Asthenia, Urine output decreased, Catheter site infection, Urosepsis, Dyspnoea, Dysuria, Enterocolitis, Euglycaemic diabetic ketoacidosis, Gait disturbance, Gastrointestinal wall thickening, Hyperkalaemia, Lactic acidosis, Pyuria, Urinary tract infection, Diarrhoea, Rhabdomyolysis, |
||||
MIRTAZAPINE, DAPAGLIFLOZIN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, AMLODIPINE BESYLATE, HYDROCHLOROTHIAZIDE, IRBESARTAN, |
||||
584 | 25030138 |
US |
74 | 1 |
COVID-19, Atrial fibrillation, Syncope, Heart valve incompetence, Gait disturbance, Weight decreased, |
||||
AGALSIDASE BETA, AGALSIDASE BETA, |
||||
585 | 25030279 |
CO |
57 | 2 |
Decreased immune responsiveness, Joint destruction, Decreased appetite, Concomitant disease aggravated, Drug ineffective, General physical health deterioration, Body height decreased, Pain in extremity, Mobility decreased, Pulmonary mass, Vomiting, Fatigue, Gait disturbance, |
||||
RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, LETROZOLE, LETROZOLE, LETROZOLE, PREGABALIN, PREGABALIN, LOSARTAN, |
||||
586 | 25030299 |
US |
||
Arteriosclerosis coronary artery, Drug ineffective, Fatigue, Asthenia, Chest pain, Pain in extremity, Gait disturbance, Mastication disorder, Incorrect dose administered, |
||||
RAVULIZUMAB, |
||||
587 | 25030440 |
GB |
2 | |
Cognitive disorder, Gait disturbance, Condition aggravated, Balance disorder, Asthenia, Product substitution issue, |
||||
TERIFLUNOMIDE, AMLODIPINE, TERIFLUNOMIDE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, MIRABEGRON, |
||||
588 | 25030444 |
US |
||
Rheumatoid arthritis, Product dose omission issue, Pain, Gait disturbance, Skin lesion, |
||||
DICLOFENAC, DICLOFENAC SODIUM, TOFACITINIB, |
||||
589 | 25030553 |
CA |
44 | 2 |
Pulmonary fibrosis, Mobility decreased, Anti-cyclic citrullinated peptide antibody positive, Blister, Synovitis, Swollen joint count increased, Swelling, Systemic lupus erythematosus, Hypersensitivity, Alopecia, Maternal exposure during pregnancy, Rash, Pain, Type 2 diabetes mellitus, Contusion, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Condition aggravated, Rheumatoid arthritis, Musculoskeletal stiffness, Hand deformity, Folliculitis, Glossodynia, Abdominal discomfort, Drug tolerance decreased, Rheumatic fever, Confusional state, Headache, Arthropathy, Nausea, General physical health deterioration, Hypertension, Pemphigus, Dyspnoea, Gait disturbance, Contraindicated product administered, Arthralgia, Gastrointestinal disorder, Migraine, Discomfort, Joint swelling, Lower respiratory tract infection, Vomiting, Muscle injury, Pyrexia, Dyspepsia, Off label use, Product use issue, Prescribed underdose, Drug ineffective, Impaired healing, Wound, Exposure during pregnancy, Nasopharyngitis, Therapeutic product effect decreased, Pruritus, Helicobacter infection, Rheumatoid factor positive, Blood cholesterol increased, Sinusitis, Pericarditis, Pneumonia, Treatment failure, Ill-defined disorder, Infection, Peripheral swelling, Irritable bowel syndrome, Weight increased, Drug intolerance, Duodenal ulcer perforation, Infusion related reaction, Pain in extremity, Fatigue, |
||||
DICLOFENAC, DICLOFENAC SODIUM, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, TOFACITINIB, TOFACITINIB, LEFLUNOMIDE, LEFLUNOMIDE, PREDNISONE, HYDROCORTISONE, HYDROCORTISONE, ACETAMINOPHEN AND CODEINE, CORTISONE ACETATE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, HYDROCORTISONE, HYDROCORTISONE, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, FOLIC ACID, FOLIC ACID, FOLIC ACID, ACETAMINOPHEN AND CODEINE, RITUXIMAB, RITUXIMAB, SULFAMETHOXAZOLE AND TRIMETHOPRIM, OXYCODONE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, HYDROXYCHLOROQUINE, GOLIMUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ALENDRONATE SODIUM, ADALIMUMAB, ADALIMUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, ETANERCEPT, ETANERCEPT, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, INFLIXIMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, TOFACITINIB, DESOXIMETASONE, DESOXIMETASONE, LEFLUNOMIDE, OXYCODONE HYDROCHLORIDE, OXYCODONE, SULFASALAZINE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, GOLIMUMAB, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, USTEKINUMAB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, ALENDRONATE SODIUM, CAFFEINE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, |
||||
590 | 25030561 |
MX |
36 | 1 |
Off label use, Gait disturbance, Fatigue, Hypoaesthesia, Dizziness, Muscular weakness, Gait inability, |
||||
RITUXIMAB, |
||||
591 | 25030616 |
GB |
2 | |
Ankle fracture, Fall, Gait disturbance, Asthenia, Gait inability, |
||||
INTERFERON BETA-1A, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, PREGABALIN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, AMLODIPINE, FOLIC ACID, CYANOCOBALAMIN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
592 | 25030695 |
HN |
71 | 2 |
Haemorrhage, Meningioma benign, Blood sodium decreased, Syncope, Fall, Head injury, Gait disturbance, |
||||
593 | 25030744 |
CA |
36 | 2 |
Ankylosing spondylitis, Nasopharyngitis, Joint range of motion decreased, Musculoskeletal stiffness, Wrong technique in device usage process, Nausea, Arthralgia, Gait disturbance, Weight bearing difficulty, Dysstasia, Drug ineffective, Joint swelling, Chest pain, Off label use, Pigmentation disorder, Headache, Dermatitis allergic, Fatigue, |
||||
DICLOFENAC, DICLOFENAC SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, CELECOXIB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, DICLOFENAC, DICLOFENAC SODIUM, GOLIMUMAB, |
||||
594 | 25030791 |
US |
60 | 2 |
Blood pressure diastolic decreased, Gait disturbance, Headache, Fall, Blood glucose increased, Hypotension, |
||||
EVOLOCUMAB, PREDNISONE, |
||||
595 | 25031247 |
CA |
||
Dysstasia, Balance disorder, Defaecation urgency, Gait disturbance, Grunting, Hypotension, Ill-defined disorder, Malaise, Pulmonary oedema, Diarrhoea, Rash pruritic, Asthenia, Pain, Fatigue, Injection site pain, Cardiac disorder, Cardiac failure congestive, Cough, Hypersensitivity, Pruritus, Urticaria, Vomiting, Drug ineffective, Wrong technique in product usage process, General physical health deterioration, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, AMLODIPINE, HYDROXYCHLOROQUINE, LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE, LOSARTAN, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, METHYLPREDNISOLONE, ROSUVASTATIN CALCIUM, |
||||
596 | 25031367 |
FR |
45 | 2 |
Paralysis, Neuralgia, Neuropathy peripheral, Gait inability, Fatigue, Insomnia, Pain in extremity, Gait disturbance, |
||||
CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, |
||||
597 | 25031462 |
DE |
31 | 2 |
Depression, Heart rate increased, Off label use, Intentional product use issue, Fall, Muscle spasticity, Gait disturbance, Gait disturbance, Alopecia, Neuralgia, Asthma, Pain, Cough, Breast mass, Oropharyngeal pain, Bronchitis, Sleep disorder, Fatigue, Agitation, Tension, Blood immunoglobulin G decreased, Stomatitis, Weight increased, |
||||
PREGABALIN, PREGABALIN, PREGABALIN, PREGABALIN, OCRELIZUMAB, OCRELIZUMAB, OCRELIZUMAB, OCRELIZUMAB, OCRELIZUMAB, OCRELIZUMAB, OCRELIZUMAB, OCRELIZUMAB, OCRELIZUMAB, AMITRIPTYLINE HYDROCHLORIDE, BACLOFEN, BACLOFEN, BACLOFEN, BACLOFEN, BACLOFEN, BACLOFEN, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, CANDESARTAN, AMLODIPINE, AMLODIPINE, AMLODIPINE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, AMANTADINE, AMANTADINE, AMANTADINE, |
||||
598 | 25031585 |
CA |
||
Orchitis, Dementia Alzheimer^s type, Testicular abscess, Pyrexia, Drug ineffective, Gait disturbance, |
||||
TIOTROPIUM BROMIDE INHALATION SPRAY, ALBUTEROL SULFATE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
599 | 25031805 |
US |
14 | 1 |
Balance disorder, Gait disturbance, |
||||
AVAPRITINIB, |
||||
600 | 25031844 |
IT |
63 | 1 |
Myalgia, Muscle spasms, Gait disturbance, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28